gptkbp:instance_of
|
gptkb:genus
|
gptkbp:cause
|
gptkb:Leishmaniasis
|
gptkbp:contributes_to
|
public health issues
displacement of populations
economic burden
|
gptkbp:diagnosis
|
blood tests
biopsy
skin tests
|
gptkbp:geographic_distribution
|
gptkb:Africa
gptkb:Asia
gptkb:South_America
Mediterranean region
|
gptkbp:has_features
|
amastigotes
flagellated promastigotes
|
gptkbp:hosts
|
gptkb:Dog
gptkb:humans
rodents
|
https://www.w3.org/2000/01/rdf-schema#label
|
Leishmania species
|
gptkbp:includes
|
gptkb:Leishmania_braziliensis
gptkb:Leishmania_donovani
gptkb:Leishmania_infantum
gptkb:Leishmania_major
|
gptkbp:is_found_in
|
tropical and subtropical regions
|
gptkbp:life_cycle
|
digenetic
|
gptkbp:prevention
|
gptkb:Wasp
vaccination research
bed nets
|
gptkbp:related_to
|
gptkb:HIV/_AIDS
malnutrition
immunosuppression
|
gptkbp:research
|
genetic diversity
host-parasite interactions
pathogenesis
|
gptkbp:research_focus
|
vector control
vaccine development
treatment resistance
|
gptkbp:seed_dispersal
|
approximately 30 Mb
|
gptkbp:symptoms
|
gptkb:anemia
gptkb:cutaneous_leishmaniasis
weight loss
fever
skin ulcers
mucocutaneous leishmaniasis
visceral leishmaniasis
|
gptkbp:transmission
|
sandfly bites
|
gptkbp:treatment
|
gptkb:amphotericin_B
gptkb:miltefosine
treatment adherence
drug toxicity
emerging resistance
antimonials
liposomal amphotericin B
paromomycin
|
gptkbp:vector
|
gptkb:Lutzomyia_sandflies
gptkb:Phlebotomus_sandflies
|
gptkbp:bfsParent
|
gptkb:pentamidine
|
gptkbp:bfsLayer
|
6
|